IVF

INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021

Thursday, October 14, 2021 - 2:00pm

This becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama and Atlanta, Georgia.

Key Points: 
  • This becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama and Atlanta, Georgia.
  • Positib Fertility, an INVO Center, is a partnership between INVO Bioscience and experienced reproductive specialist Dr. Francisco Arredondo, MD., MPH and Dr. Ramiro Ramirez Gutierrez, MD.
  • Dr. Arredondo successfully sold his U.S.-based fertility clinics in 2019 and is now focused on bringing the INVOcell solution to Mexico.
  • Steve Shum, CEO of INVO Bioscience, commented, "This is yet another milestone in the history of the Company and the INVOcell solution as we announce the grand opening of our first INVO Center in Mexico.

Advancements in reproductive medicine available at Shady Grove Fertility (SGF) can reduce the inheritance of genetic diseases like breast cancer

Thursday, October 14, 2021 - 1:45pm

Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.

Key Points: 
  • Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.
  • Additionally, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases.
  • While Rose is not a carrier for the breast cancer gene, she is a carrier of a rare X-linked genetic mutation called Wiskott-Aldrich syndrome.
  • We are so fortunate to live in a world where we can now reduce the inheritance of deadly genetic diseases via IVF.

CCRM Fertility Colorado and TMRW Life Sciences Partner in State-of-the-Art Technology for the Safe Management of Eggs and Embryos for IVF Patients

Thursday, October 14, 2021 - 1:00pm

"In partnership with TMRW, we're implementing new capabilities for the safe management of eggs and embryos, including software-guided specimen management, 24/7 remote monitoring, unique digital identification for each sample and touch-of-a-button inventory management within the lab."

Key Points: 
  • "In partnership with TMRW, we're implementing new capabilities for the safe management of eggs and embryos, including software-guided specimen management, 24/7 remote monitoring, unique digital identification for each sample and touch-of-a-button inventory management within the lab."
  • TMRW Life Sciences has created the first automated solution for how frozen eggs and embryos are stored, tracked, and monitored during the IVF process.
  • The TMRW platform is transforming the possibilities for fertility and family planning by safeguarding the most precious cells for life.
  • Founded by Dr. William Schoolcraft in 1987, CCRM (Colorado Center for Reproductive Medicine)Fertilityis the nation's leader in fertility care and research.

Cicero Diagnostics reaches 10,000-patient milestone with its ReceptivaDx™ Test

Thursday, October 14, 2021 - 11:00am

Womens healthcare company, Cicero Diagnostics Inc., offering ReceptivaDx for unexplained infertility, implantation failure and recurrent pregnancy loss, today announced it has reached the 10,000-patient mark from fertility centers using ReceptivaDx and its signature BCL6 marker.

Key Points: 
  • Womens healthcare company, Cicero Diagnostics Inc., offering ReceptivaDx for unexplained infertility, implantation failure and recurrent pregnancy loss, today announced it has reached the 10,000-patient mark from fertility centers using ReceptivaDx and its signature BCL6 marker.
  • The milestone signifies substantial test growth since the companys inception and reflects the role ReceptivaDx now plays as a new standard of care in fertility centers helping patients who have experienced IVF failure.
  • Today ReceptivaDx is used by more than 350 fertility centers around the country and has been introduced in several strategic international markets with more expected, said Chris Jackson, CEO Cicero Diagnostics.
  • Cicero Diagnostics is the exclusive licensed provider of the BCL6 test for the detection of uterine lining dysfunction commonly associated with endometriosis.

SGF Jones Institute physician, Tarita Pakrashi, M.D., M.P.H., named to Coastal Virginia Magazine's 2021 Top Doctors list

Wednesday, October 13, 2021 - 10:30pm

NORFOLK, Va., Oct. 13, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) is proud to announce that Tarita Pakrashi, M.D., M.P.H ., who sees patients at SGF Jones Institute in Norfolk , has been named to Coastal Virginia Magazine's 2021 Top Doctors list.

Key Points: 
  • NORFOLK, Va., Oct. 13, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) is proud to announce that Tarita Pakrashi, M.D., M.P.H ., who sees patients at SGF Jones Institute in Norfolk , has been named to Coastal Virginia Magazine's 2021 Top Doctors list.
  • Coastal Virginia Magazine conducts an annual peer-to-peer survey by Data Joe, an independent firm with no ties to the magazine or the medical community.
  • The 2021 Top Docs list is compiled of 668 physicians across 80 specialties.
  • SGF Jones Institute provides a full range of diagnostic and treatment options to help individuals and couples achieve their family-building goals, including:

New testing device from March of Dimes Prematurity Research Center at Imperial College London allows for rapid detection of bacteria that identify risk for preterm birth

Wednesday, October 13, 2021 - 10:00am

ARLINGTON, Va., Oct. 13, 2021 /PRNewswire/ -- Researchers at the March of Dimes Prematurity Research Center at Imperial College London have developed a first-of-its-kind testing device that may help advance diagnosis and treatment of preterm birth.

Key Points: 
  • ARLINGTON, Va., Oct. 13, 2021 /PRNewswire/ -- Researchers at the March of Dimes Prematurity Research Center at Imperial College London have developed a first-of-its-kind testing device that may help advance diagnosis and treatment of preterm birth.
  • In some women, certain bacteria from the microbiome can cause inflammation leading to an increased risk of preterm birth.
  • March of Dimes, the infant and maternal health leader, is dedicated to advancing knowledge and solutions for preterm birth.
  • At Imperial College London, research is highlighting the important role of the reproductive tract microbiome in shaping preterm birth risk and other pregnancy outcomes.

New testing device from March of Dimes Prematurity Research Center at Imperial College London allows for rapid detection of bacteria that identify risk for preterm birth

Wednesday, October 13, 2021 - 10:00am

ARLINGTON, Va., Oct. 13, 2021 /PRNewswire/ -- Researchers at the March of Dimes Prematurity Research Center at Imperial College London have developed a first-of-its-kind testing device that may help advance diagnosis and treatment of preterm birth. A study, published in Nature Communications, finds that the device can rapidly and accurately detect changes in vaginal bacteria and corresponding immune responses in pregnant women, which are associated with increased risk of preterm birth. This cost-effective test could facilitate faster clinical decision making and help improve targeted treatment strategies during pregnancy.

Key Points: 
  • ARLINGTON, Va., Oct. 13, 2021 /PRNewswire/ -- Researchers at the March of Dimes Prematurity Research Center at Imperial College London have developed a first-of-its-kind testing device that may help advance diagnosis and treatment of preterm birth.
  • In some women, certain bacteria from the microbiome can cause inflammation leading to an increased risk of preterm birth.
  • March of Dimes, the infant and maternal health leader, is dedicated to advancing knowledge and solutions for preterm birth.
  • At Imperial College London, research is highlighting the important role of the reproductive tract microbiome in shaping preterm birth risk and other pregnancy outcomes.

First Fertility Launches, Sets Stage for Growth

Tuesday, October 12, 2021 - 1:00pm

AVON, Connecticut, Oct. 12, 2021 (GLOBE NEWSWIRE) -- First Fertility, a leading fertility company focused on patient experience, has launched its brand with plans to accelerate growth nationwide.

Key Points: 
  • AVON, Connecticut, Oct. 12, 2021 (GLOBE NEWSWIRE) -- First Fertility, a leading fertility company focused on patient experience, has launched its brand with plans to accelerate growth nationwide.
  • "We are building a network of best-in-class IVF centers with the singular purpose of putting our patients first," commented Derek Larkin, CEO of First Fertility.
  • "Each of our investments and innovations will be focused on continually improving the experiences of our patients.
  • Now, as we grow with these strategic partnerships and acquisitions, First Fertility will bring positive and transformative opportunity for fertility care in the United States."

Biotech Inc. Welcomes Marc Brignola Vice President of Global Sales Accelerating Its Growth and Expansion Plans

Tuesday, October 12, 2021 - 12:00pm

ALPHARETTA, Ga., Oct. 12, 2021 /PRNewswire-PRWeb/ -- Biotech Inc. is pleased to announce that Marc Brignola, ART Device Sales Executive is joining the company as the Global Vice President of Sales.

Key Points: 
  • ALPHARETTA, Ga., Oct. 12, 2021 /PRNewswire-PRWeb/ -- Biotech Inc. is pleased to announce that Marc Brignola, ART Device Sales Executive is joining the company as the Global Vice President of Sales.
  • Marc was most recently the Senior Director, Worldwide Sales for FUJIFILM Irvine Scientific.
  • "I am honored to work with Biotech, exploring new growth avenues within my current base of strong IVF/ART relationships."
  • said Marc Brignola, VP of Global Sales, Biotech Inc.
    Biotech Inc. designs and produces instruments and/or tools for laboratory use on human and animal bioscience research.

Shady Grove Fertility (SGF) expands egg donation program to Allentown, PA

Monday, October 11, 2021 - 1:10pm

ALLENTOWN, Pa., Oct. 11, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) , home to one of the largest egg donor programs in the country, now offers full-service egg donation intheir Allentown, PA , location.

Key Points: 
  • ALLENTOWN, Pa., Oct. 11, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) , home to one of the largest egg donor programs in the country, now offers full-service egg donation intheir Allentown, PA , location.
  • SGF recruits and medically, psychologically, and genetically prescreens all prospective, ready-to-cycle egg donors prior to listing them on the SGF donor registry .
  • Under SGF's stringent screening requirements, any prospective egg donor between the ages of 21-34 who is healthy and has knowledge of their family history may be considered for egg donation.
  • To learn more about becoming an egg donor at SGF including eligibility requirements, the donation process, compensation, and egg donation FAQS visit Become an Egg Donor , or complete your initial egg donor application .